Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
about
Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infectionToll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infectionPathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTPMacrophages and cytokines in the early defence against herpes simplex virusIL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer CellsUpregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell CytotoxicityJinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosisFlt3 permits survival during infection by rendering dendritic cells competent to activate NK cellsSpecific dysregulation of IFNγ production by natural killer cells confers susceptibility to viral infectionInactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infectionDifferential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 virusesDeficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins.Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological functionTonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.NK cell-like behavior of Valpha14i NK T cells during MCMV infection.NK cells and apoptosis.Cytomegalovirus evasion of natural killer cell responses.Regulation of human NK-cell cytokine and chemokine production by target cell recognition.Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeActivation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic miceRole of interleukin-12 in primary influenza virus infectionT-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signalingAlternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependentPersistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surfaceHuman natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms.Endogenous interleukin-12 is not required for resolution of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection in mice.Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everythingDifferential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.Natural killer cells inhibit hepatitis C virus expression.Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infectionVigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.
P2860
Q24520487-8BBC0DE9-0EE7-480A-8941-812EE3249DBFQ24531350-BA903A68-5117-4177-8992-76BEB8D7BE90Q24633526-E696768E-233F-4EB0-AFFC-342DDE41F6DEQ24679086-C39B3F29-8ADC-4555-9EF6-3EB181F6EB26Q24815062-0FF9865A-B35E-4D9F-96B5-770A729D0FBDQ26800159-75DF9950-2AE8-442D-9030-7868C5CF3084Q27477668-4063D257-53AA-458B-88FC-C124B84D6831Q28506181-6DB40AF4-AF52-4C21-B256-881EB9F8425EQ28512098-423735A3-8D85-431B-9870-22FCB0D17F12Q28542517-92924964-BA40-4254-A93C-E2908366A32BQ28586576-6A3714B2-F760-496E-8AE1-7E9598D78985Q30389411-818E5634-6CBA-4EE9-8259-0F2DE5DF1810Q30441926-EA7F0F4F-4855-4D93-AA8E-F51D40796998Q30486283-8EB18D15-C529-45E8-8D28-F70C56E0D5AEQ33319277-6CA06413-B63B-4DC7-92A7-F0EE88119E1AQ33352690-8D0CAC8C-0906-48D7-85A3-05DF2BA937A6Q33547794-826F6D2D-E026-4A4F-887C-C9517ED5E8E0Q33683395-C850172D-76F3-4B05-9E21-54C5693EA197Q33747309-01C71E70-A6C7-48E4-98A0-40BA51CC7F12Q33752757-CEEC0294-027E-4DDC-BCB1-7EB452280B6DQ33767460-F983DB12-9606-42A5-96F5-D6C3FF46E0BFQ33769282-7DEAE9EB-17BB-4347-AA62-22413C283522Q33782029-4C2ADEB8-F703-459A-8D2F-F7D00C525753Q33782971-E89E90CE-BB38-4341-BF70-3E68129FF175Q33784078-6C09AAD9-86DE-40AC-B526-BCFD6B1AC8B6Q33792958-A4230941-7BFD-4975-A2E1-A9037692E435Q33847030-079B0D68-B739-4E27-B1A0-32285F79F394Q33852869-AE5982F6-47FF-4ED6-939E-8A738AD1ECB9Q33874809-1AE69C86-0252-4668-A0CB-A4402246C932Q33886108-B13DD245-B16E-45C8-A4A5-30DF689191D3Q34006469-FB8974CC-F9C5-4845-9AD6-39E99A2F19E0Q34008500-D2FF2917-61C1-4F86-8711-9D77329BFE32Q34013634-1FEA4BFC-53C2-4FA7-B9D3-6E51751A0B13Q34022257-476E509D-FEE4-4F2C-9DB3-0C9F0A21D814Q34150316-2B690F52-C27D-4C28-95F6-F2747EC63D0CQ34344742-80777C9D-6076-4B60-80E0-8DE2DB782AF3Q34356255-71118913-CF58-43A8-B107-D4A7B0B9240BQ34364808-ACA959D8-DDC7-46EC-9ADF-342098B5CB8BQ34404551-BD130C63-AAD5-4093-A863-693E91C66A33Q34465970-6ED55F99-42D5-4D72-BCD9-F6F4F1457B37
P2860
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Requirement for natural killer ...... interleukin 12 administration.
@ast
Requirement for natural killer ...... interleukin 12 administration.
@en
type
label
Requirement for natural killer ...... interleukin 12 administration.
@ast
Requirement for natural killer ...... interleukin 12 administration.
@en
prefLabel
Requirement for natural killer ...... interleukin 12 administration.
@ast
Requirement for natural killer ...... interleukin 12 administration.
@en
P2093
P2860
P356
P1476
Requirement for natural killer ...... interleukin 12 administration.
@en
P2093
P2860
P304
P356
10.1084/JEM.182.4.1045
P407
P577
1995-10-01T00:00:00Z